Does RUXOLITINIB Cause Off label use? 12,492 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12,492 reports of Off label use have been filed in association with RUXOLITINIB (OPZELURA). This represents 18.3% of all adverse event reports for RUXOLITINIB.
12,492
Reports of Off label use with RUXOLITINIB
18.3%
of all RUXOLITINIB reports
1,527
Deaths
1,769
Hospitalizations
How Dangerous Is Off label use From RUXOLITINIB?
Of the 12,492 reports, 1,527 (12.2%) resulted in death, 1,769 (14.2%) required hospitalization, and 111 (0.9%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 12,492 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
Headache (2,271)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which RUXOLITINIB Alternatives Have Lower Off label use Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE